Accelerated iTBS for Major Depression
NCT: NCT07603804 · RECRUITING
Brief Summary
Major depressive disorder (MDD) is a common and disabling psychiatric condition, and many patients do not achieve adequate response to standard antidepressant treatments. Accelerated intermittent theta burst stimulation (iTBS) is a promising neuromodulation approach that may provide rapid antidepressant effects. This prospective interventional study aims to evaluate the clinical effectiveness of accelerated bilateral dorsomedial prefrontal cortex iTBS in patients with MDD and to investigate treatment-related changes in neurobiological biomarkers, including cortisol, ACTH, BDNF, IL-1β, IL-6, TNF-α, and CRP. Associations between biomarker changes and treatment response will also be examined.
Frequently Asked Questions
What is Accelerated iTBS for Major Depression?
Accelerated iTBS for Major Depression is a clinical trial registered under NCT07603804. Current status: RECRUITING.
What is the status of NCT07603804?
The current status of NCT07603804 (Accelerated iTBS for Major Depression) is: RECRUITING.
When did Accelerated iTBS for Major Depression start?
Accelerated iTBS for Major Depression started on 2026-03-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.